Long-term outcome of childhood-onset complicated nephrotic syndrome after a multicenter, double-blind, randomized, placebo-controlled trial of rituximab

被引：0

作者：

Koichi Kamei

Kenji Ishikura

Mayumi Sako

Kunihiko Aya

Ryojiro Tanaka

Kandai Nozu

Hiroshi Kaito

Koichi Nakanishi

Yoshiyuki Ohtomo

Kenichiro Miura

Shori Takahashi

Tetsuji Morimoto

Wataru Kubota

Shuichi Ito

Hidefumi Nakamura

Kazumoto Iijima

机构：

[1] National Center for Child Health and Development,Division of Nephrology and Rheumatology

[2] National Center for Child Health and Development,Division for Clinical Trials, Department of Clinical Research, Center for Clinical Research and Development

[3] Kurashiki Central Hospital,Department of Pediatrics

[4] Hyogo Prefectural Kobe Children’s Hospital,Department of Nephrology

[5] Kobe University Graduate School of Medicine,Department of Pediatrics

[6] University of the Ryukyus,Department of Child Health and Welfare (Pediatrics), Graduate School of Medicine

[7] Juntendo University Nerima Hospital,Department of Pediatrics

[8] Tokyo Women’s Medical University,Department of Pediatric Nephrology

[9] School of Medicine,Department of Pediatrics

[10] Nihon University Itabashi Hospital,Division of Pediatrics

[11] Tohoku Medical and Pharmaceutical University Hospital,Department of Nephrology

[12] Tokyo Metropolitan Children’s Medical Center,Department of Pediatrics, Graduate School of Medicine

[13] Yokohama City University,Department of Development Strategy, Center for Clinical Research and Development

[14] National Center for Child Health and Development,undefined

来源：

Pediatric Nephrology | 2017年 / 32卷

关键词：

Complicated nephrotic syndrome; Steroid-dependent nephrotic syndrome; Frequently relapsing nephrotic syndrome; Rituximab; Immunosuppressive agents;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

页码：2071 / 2078

页数：7

共 50 条

[1] Long-term outcome of childhood-onset complicated nephrotic syndrome after a multicenter, double-blind, randomized, placebo-controlled trial of rituximab
Kamei, Koichi
Ishikura, Kenji
Sako, Mayumi
Aya, Kunihiko
Tanaka, Ryojiro
Nozu, Kandai
Kaito, Hiroshi
Nakanishi, Koichi
Ohtomo, Yoshiyuki
Miura, Kenichiro
Takahashi, Shori
Morimoto, Tetsuji
Kubota, Wataru
Ito, Shuichi
Nakamura, Hidefumi
Iijima, Kazumoto
PEDIATRIC NEPHROLOGY, 2017, 32 (11) : 2071 - 2078
[2] Multicenter, Double-Blind, Placebo-Controlled, Randomized Trial of Rituximab for the Treatment of Childhood-Onset Refractory Nephrotic Syndrome
Iijima, Kazumoto
Sako, Mayumi
Nozu, Kandai
Tsuchida, Nao
Tanaka, Ryojiro
Ishikura, Kenji
Ito, Shuichi
Ohashi, Yasuo
PEDIATRIC NEPHROLOGY, 2013, 28 (08) : 1362 - 1363
[3] Rituximab for childhood-onset, complicated, frequently relapsing nephrotic syndrome or steroid-dependent nephrotic syndrome: a multicentre, double-blind, randomised, placebo-controlled trial
Iijima, Kazumoto
Sako, Mayumi
Nozu, Kandai
Mori, Rintaro
Tuchida, Nao
Kamei, Koichi
Miura, Kenichiro
Aya, Kunihiko
Nakanishi, Koichi
Ohtomo, Yoshiyuki
Takahashi, Shori
Tanaka, Ryojiro
Kaito, Hiroshi
Nakamura, Hidefumi
Ishikura, Kenji
Ito, Shuichi
Ohashi, Yasuo
LANCET, 2014, 384 (9950): : 1273 - 1281
[4] Study protocol: mycophenolate mofetil as maintenance therapy after rituximab treatment for childhood-onset, complicated, frequently-relapsing nephrotic syndrome or steroid-dependent nephrotic syndrome: a multicenter double-blind, randomized, placebo-controlled trial (JSKDC07)
Tomoko Horinouchi
Mayumi Sako
Koichi Nakanishi
Kenji Ishikura
Shuichi Ito
Hidefumi Nakamura
Mari Saito Oba
Kandai Nozu
Kazumoto Iijima
BMC Nephrology, 19
[5] Study protocol: mycophenolate mofetil as maintenance therapy after rituximab treatment for childhood-onset, complicated, frequently-relapsing nephrotic syndrome or steroid-dependent nephrotic syndrome: a multicenter double-blind, randomized, placebo-controlled trial (JS']JSKDC07)
Horinouchi, Tomoko
Sako, Mayumi
Nakanishi, Koichi
Ishikura, Kenji
Ito, Shuichi
Nakamura, Hidefumi
Oba, Mari Saito
Nozu, Kandai
Iijima, Kazumoto
BMC NEPHROLOGY, 2018, 19
[6] Rituximab to treat childhood nephrotic syndrome complicated with frequent relapses or corticoid: a multicenter, double blind, randomized placebo controlled study
Briones, Liliana
ARCHIVOS ARGENTINOS DE PEDIATRIA, 2015, 113 (01): : 95 - 96
[7] Study protocol: multicenter double-blind, randomized, placebo-controlled trial of rituximab for the treatment of childhood-onset early-stage uncomplicated frequently relapsing or steroid-dependent nephrotic syndrome (JSKDC10 trial)
China Nagano
Mayumi Sako
Koichi Kamei
Kenji Ishikura
Hidefumi Nakamura
Koichi Nakanishi
Takashi Omori
Kandai Nozu
Kazumoto Iijima
BMC Nephrology, 20
[8] Rituximab for Adult-Onset Frequently Relapsing or Steroid-Dependent Nephrotic Syndrome: A Multicenter, Double-Blind, Randomized, Placebo Controlled Trial
Isaka, Yoshitaka
Maruyama, Shoichi
Sakaguchi, Mika
Hayashi, Hiroki
Kaida, Yusuke
Goto, Shin
Tsukamoto, Tatsuo
Maeshima, Akito
Ikeda, Yoichiro
Sakai, Norihiko
Sawa, Naoki
Furuichi, Kengo
Yamagata, Kunihiro
Sakaguchi, Yusuke
Shinzawa, Maki
Wada, Takehiko
Shibagaki, Yugo
Hiromura, Keiju
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2024, 35 (10):
[9] Study protocol: multicenter double-blind, randomized, placebo-controlled trial of rituximab for the treatment of childhood-onset early-stage uncomplicated frequently relapsing or steroid-dependent nephrotic syndrome (JS']JSKDC10 trial)
Nagano, China
Sako, Mayumi
Kamei, Koichi
Ishikura, Kenji
Nakamura, Hidefumi
Nakanishi, Koichi
Omori, Takashi
Nozu, Kandai
Iijima, Kazumoto
BMC NEPHROLOGY, 2019, 20 (01)
[10] Predicting Methylphenidate Response in Long-Term Survivors of Childhood Cancer: A Randomized, Double-Blind, Placebo-Controlled, Crossover Trial
Conklin, Heather M.
Helton, Susan
Ashford, Jason
Mulhern, Raymond K.
Reddick, Wilburn E.
Brown, Ronald
Bonner, Melanie
Jasper, Bruce W.
Wu, Shengjie
Xiong, Xiaoping
Khan, Raja B.
JOURNAL OF PEDIATRIC PSYCHOLOGY, 2010, 35 (02) : 144 - 155

← 1 2 3 4 5 →